Indeed, overexpression of CD95L and inadequate activation of the CD95 system which results in a pro-apoptotic BM milieu has been demonstrated in MDS and appears to contribute to the anemia observed in patients with low-risk diseases [9,10]. This evidence concerns the gene FAS and myelodysplastic syndrome.